<DOC>
	<DOC>NCT01046136</DOC>
	<brief_summary>This is an exploratory, multicenter, randomized, blinded, placebo-controlled study of Mucinex in patients with colds. Patients will receive 7 days of treatment with either Mucinex or placebo. The study will assess the effects of Mucinex on sputum and cold symptoms.</brief_summary>
	<brief_title>Mucinex Exploratory Cold Study</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Common Cold</mesh_term>
	<mesh_term>Guaifenesin</mesh_term>
	<mesh_term>Phenylpropanolamine</mesh_term>
	<mesh_term>Chlorpheniramine, phenylpropanolamine drug combination</mesh_term>
	<criteria>common cold symptoms meet symptom severity females of childbearing potential must have negative pregnancy test and use effective birth control chronic respiratory conditions significant heart, kidney, liver, or lung disease, uncontrolled hypertension or diabetes, cystic fibrosis, thyroid disorder pregnant or lactating known malignancy participation in any other clinical trial within 30 days of baseline related to another enrolled patient or persons involved directly or indirectly with the conduct of this study</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>common cold</keyword>
</DOC>